{"DataElement":{"publicId":"1106","version":"3","preferredName":"Prostate Tumor Clinical T Stage","preferredDefinition":"extent of the primary tumor determined prior to treatment based on evidence obtained from clinical assessment parameters (physical examination, imaging, endoscopy, etc.). The AJCC staging version to use is protocol specific.","longName":"PRS_TUMOR_C_T_ST","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2188756","version":"1","preferredName":"Prostate Tumor Clinical T","preferredDefinition":"Information related to clinical T stage of a prostate tumor.","longName":"PRS_TUMOR_C_T","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206573","version":"1","preferredName":"Prostate Neoplasm","preferredDefinition":"A gland in the male reproductive system just below the bladder. It surrounds part of the urethra, the canal that empties the bladder. It produces a fluid that forms part of semen. (NCI-GLOSS):(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12410:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FA7A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207100","version":"1","preferredName":"Clinical T Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25398:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-183F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E552D669-7D8C-67B3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-30","modifiedBy":"TAYLORT","dateModified":"2018-04-09","changeDescription":"4/9/18 tt changed Reg Station and released. 9/13/17 tt transferred context; changed def - 1st letter upper case; changed Reg Status to Qualified.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018482","version":"1","preferredName":"Prostate Tumor Clinical T Stage","preferredDefinition":"the clinical T (tumor) stage for a prostate tumor.","longName":"PRS_TUMOR_C_T_ST","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T3","valueDescription":"TUMOR EXTENDS THROUGH THE PROSTATE CAPULE","ValueMeaning":{"publicId":"2560330","version":"1","preferredName":"TUMOR EXTENDS THROUGH THE PROSTATE CAPULE","longName":"2560330","preferredDefinition":"TUMOR EXTENDS THROUGH THE PROSTATE CAPULE","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8B7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DBFC78C3-BF30-3E87-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T3a","valueDescription":"EXTRACAPSULAR EXTENSION (UNILATERAL OR BILATERAL)","ValueMeaning":{"publicId":"2558764","version":"1","preferredName":"EXTRACAPSULAR EXTENSION (UNILATERAL OR BILATERAL)","longName":"2558764","preferredDefinition":"EXTRACAPSULAR EXTENSION (UNILATERAL OR BILATERAL)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B299-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DBFC78C3-BF33-3E87-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T3b","valueDescription":"TUMOR INVADES SEMINAL VESICLE(S)","ValueMeaning":{"publicId":"2560340","version":"1","preferredName":"TUMOR INVADES SEMINAL VESICLE(S)","longName":"2560340","preferredDefinition":"TUMOR INVADES SEMINAL VESICLE(S)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8C1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DBFC78C3-BF36-3E87-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T4","valueDescription":"TUMOR IS FIXED OR INVADES ADJACENT STRUCTURES OTHER THAN SEMINAL VESICLES: BLADDER NECK, EXTERNAL SPHINCTER, OR RECTUM, LEVATOR MUSCLES, AND/OR PELVIC WALL","ValueMeaning":{"publicId":"2560349","version":"1","preferredName":"TUMOR IS FIXED OR INVADES ADJACENT STRUCTURES OTHER THAN SEMINAL VESICLES: BLADDER NECK, EXTERNAL SPHINCTER, OR RECTUM, LEVATOR MUSCLES, AND/OR PELVIC WALL","longName":"2560349","preferredDefinition":"TUMOR IS FIXED OR INVADES ADJACENT STRUCTURES OTHER THAN SEMINAL VESICLES: BLADDER NECK, EXTERNAL SPHINCTER, OR RECTUM, LEVATOR MUSCLES, AND/OR PELVIC WALL","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8CA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DBFC78C3-BF39-3E87-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"TX","valueDescription":"PRIMARY TUMOR CANNOT BE ASSESSED","ValueMeaning":{"publicId":"2559890","version":"1","preferredName":"PRIMARY TUMOR CANNOT BE ASSESSED","longName":"2559890","preferredDefinition":"PRIMARY TUMOR CANNOT BE ASSESSED","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6FF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DBFC78C3-BF3C-3E87-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T0","valueDescription":"No evidence of primary tumor","ValueMeaning":{"publicId":"2559524","version":"1","preferredName":"No evidence of primary tumor","longName":"2559524","preferredDefinition":"Lung cancer without any evidence of a primary tumor. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer pT0 TNM Finding v6 and v7","conceptCode":"C60966","definition":"Lung cancer without any evidence of a primary tumor. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B591-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DBFB83D5-B90F-40AC-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T1","valueDescription":"CLINICALLY INAPPARENT TUMOR NOT PALPABLE NOR VISIBLE BY IMAGING","ValueMeaning":{"publicId":"2558519","version":"1","preferredName":"CLINICALLY INAPPARENT TUMOR NOT PALPABLE NOR VISIBLE BY IMAGING","longName":"2558519","preferredDefinition":"CLINICALLY INAPPARENT TUMOR NOT PALPABLE NOR VISIBLE BY IMAGING","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B1A4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DBFB83D5-B911-40AC-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T2","valueDescription":"TUMOR CONFINED WITHIN THE PROSTATE","ValueMeaning":{"publicId":"2560327","version":"1","preferredName":"TUMOR CONFINED WITHIN THE PROSTATE","longName":"2560327","preferredDefinition":"TUMOR CONFINED WITHIN THE PROSTATE","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8B4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DBFB83D5-B914-40AC-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T2a","valueDescription":"TUMOR INVOLVES ONE LOBE","ValueMeaning":{"publicId":"2560348","version":"1","preferredName":"TUMOR INVOLVES ONE LOBE","longName":"2560348","preferredDefinition":"TUMOR INVOLVES ONE LOBE","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8C9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DBFB83D5-B917-40AC-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T2b","valueDescription":"TUMOR INVOLVES  BOTH LOBES","ValueMeaning":{"publicId":"2560347","version":"1","preferredName":"TUMOR INVOLVES  BOTH LOBES","longName":"2560347","preferredDefinition":"TUMOR INVOLVES  BOTH LOBES","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8C8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DBFB83D5-B91A-40AC-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T1b","valueDescription":"TUMOR INCIDENTAL HISTOLOGIC FINDING IN MORE THAN 5% OF TISSUE RESECTED","ValueMeaning":{"publicId":"2560333","version":"1","preferredName":"TUMOR INCIDENTAL HISTOLOGIC FINDING IN MORE THAN 5% OF TISSUE RESECTED","longName":"2560333","preferredDefinition":"TUMOR INCIDENTAL HISTOLOGIC FINDING IN MORE THAN 5% OF TISSUE RESECTED","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8BA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DBFB8B66-4609-43D3-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T1c","valueDescription":"TUMOR IDENTIFIED BY NEEDLE BIOPSY (EG, BECAUSE OF ELEVATED PSA)","ValueMeaning":{"publicId":"2560332","version":"1","preferredName":"TUMOR IDENTIFIED BY NEEDLE BIOPSY (EG, BECAUSE OF ELEVATED PSA)","longName":"2560332","preferredDefinition":"TUMOR IDENTIFIED BY NEEDLE BIOPSY (EG, BECAUSE OF ELEVATED PSA)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8B9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DBFB8B66-460C-43D3-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T1a","valueDescription":"TUMOR INCIDENTAL HISTOLOGIC FINDING IN 5% OR LESS OF TISSUE RESECTED","ValueMeaning":{"publicId":"2569760","version":"1","preferredName":"TUMOR INCIDENTAL HISTOLOGIC FINDING IN 5% OR LESS OF TISSUE RESECTED","longName":"2569760","preferredDefinition":"TUMOR INCIDENTAL HISTOLOGIC FINDING IN 5% OR LESS OF TISSUE RESECTED","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DD8D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-03","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-03","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DBFB9002-930C-40BD-E034-0003BA12F5E7","beginDate":"2004-06-03","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T2c","valueDescription":"TUMOR INVOLVES  BOTH LOBES","ValueMeaning":{"publicId":"2560347","version":"1","preferredName":"TUMOR INVOLVES  BOTH LOBES","longName":"2560347","preferredDefinition":"TUMOR INVOLVES  BOTH LOBES","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8C8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06E16344-A0E3-4C2C-E044-0003BA3F9857","beginDate":"2005-12-01","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-12-01","modifiedBy":"ONEDATA","dateModified":"2005-12-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184339","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"Stage","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20A0-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B47257EE-9848-3042-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-17","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-17","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811910","version":"1","longName":"Prostate","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811916","version":"1","longName":"Localized Prostate","context":"CTEP"}]},{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812151","version":"1","longName":"Prostate - Lycopene","context":"DCP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171064","version":"1","longName":"RTOG-0815","context":"NRG"}]}],"AlternateNames":[{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"PRS_TUMOR_C_T_ST","type":"USED_BY","context":"NRG"},{"name":"Theradex","type":"USED_BY","context":"Theradex"}],"ReferenceDocuments":[{"name":"CRF Text","type":"Alternate Question Text","description":"T Stage, Clinical","url":null,"context":"CTEP"},{"name":"Clinical T Stage","type":"Preferred Question Text","description":"Clinical T Stage","url":null,"context":"CTEP"},{"name":"1-COMMENT","type":"COMMENT","description":"Note: Use the AJCC staging system specified in the protocol","url":null,"context":"CTEP"},{"name":"DCP Document Text","type":"Alternate Question Text","description":"T-stage, Pathologic","url":null,"context":"DCP"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"T Stage","url":null,"context":"Theradex"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B472F9B7-6AD5-3433-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-17","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-17","modifiedBy":"TAYLORT","dateModified":"2018-07-19","changeDescription":"ISO 11179 Compliance.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}